Viewing Study NCT05304169


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2025-12-25 @ 8:16 PM
Study NCT ID: NCT05304169
Status: COMPLETED
Last Update Posted: 2022-03-31
First Post: 2022-03-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual.
Sponsor: Zodiac Produtos Farmaceuticos S.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module